Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels

Am J Transplant. 2009 Nov;9(11):2571-9. doi: 10.1111/j.1600-6143.2009.02814.x. Epub 2009 Sep 22.

Abstract

We prospectively assessed the evolution of coronary artery calcification (CAC) and osteoprotegerin (OPG) levels after renal transplantation (RT). Eighty-three recipients were followed-up prospectively during 1 year. Blood was collected before (baseline) and after RT for determination of mineral metabolism parameters including OPG. CAC was measured by multidetector computed tomography at transplantation (baseline) and 1 year later. Progression of CAC was defined as a difference between the follow-up square-root transformed volume (SRV) and the baseline SRV >or= 2.5. By multivariate analysis, baseline OPG level, age and low LDL levels were significantly associated with baseline CAC. RT was accompanied by mineral metabolism improvement with a decrease of OPG from 955 [395-5652] to 527 [217-1818] pg/mL and parathyroid hormone from 94 [1-550] to 62 [16-410] pg/mL. Thirty-one percent of patients did not exhibit CAC at baseline. CAC diminished in 14.5%, stabilized in 59.2% and progressed in 26.3% of patients. Baseline CAC was associated with progression (OR 2.92 [1.02-8.36]). No significant association was found between OPG and CAC progression despite a higher baseline OPG level in progressors (1046 [456-3285]) vs. non-progressors (899 [396-5952] pg/mL). CAC at baseline, but not 1 year after RT, is independently associated with baseline OPG; posttransplant CAC progression is predicted by baseline CAC score.

MeSH terms

  • Adult
  • Aged
  • Calcinosis / mortality*
  • Calcinosis / pathology*
  • Coronary Artery Disease / mortality*
  • Coronary Artery Disease / pathology*
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / pathology
  • Kidney Transplantation / standards*
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Osteoprotegerin / blood*
  • Parathyroid Hormone / blood
  • Predictive Value of Tests
  • Prospective Studies
  • ROC Curve
  • Risk Factors
  • Young Adult

Substances

  • Osteoprotegerin
  • Parathyroid Hormone
  • TNFRSF11B protein, human